Table 4.
HACAs | Therapeutic IFX | Non-therapeutic IFX | Non-interpretable | |
---|---|---|---|---|
Loss of response/partial response (n=110) | 19 (17) | 36 (33) | 50 (45) | 5 (5) |
Autoimmune/delayed hypersensitivity reactions (n=16) | 6 (38) | 5 (31) | 4 (25) | 1 (6) |
Acute infusion reaction (n=5) | 1 (20) | 3 (60) | 1 (20) | |
Reintroduction after drug holiday (n=7) | 6 (86) | 1 (14) |
HACAs, human anti-chimeric antibodies; IFX, infliximab.